Your browser doesn't support javascript.
loading
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
Jiménez, Daniel; Martínez-Sanz, Javier; Sainz, Talía; Calvo, Cristina; Méndez-Echevarría, Ana; Moreno, Elena; Blázquez-Gamero, Daniel; Vizcarra, Pilar; Rodríguez, Mario; Jenkins, Robert; Sánchez-Conde, Matilde; Ron, Raquel; Norman, Francesca; Moreno, Santiago; Ferrer, Manuel; Serrano-Villar, Sergio.
Afiliação
  • Jiménez D; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Martínez-Sanz J; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain. Electronic address: javier.martinez.sanz@salud.madrid.org.
  • Sainz T; Department of Pediatrics, Tropical and Infectious Diseases, Hospital La Paz, and La PazResearch Institute (IdiPAZ), Traslational Research Network of Pediatric Infectious Diseases (RITIP), and CIBERINFEC, Madrid, Spain.
  • Calvo C; Department of Pediatrics, Tropical and Infectious Diseases, Hospital La Paz, and La PazResearch Institute (IdiPAZ), Traslational Research Network of Pediatric Infectious Diseases (RITIP), and CIBERINFEC, Madrid, Spain.
  • Méndez-Echevarría A; Department of Pediatrics, Tropical and Infectious Diseases, Hospital La Paz, and La PazResearch Institute (IdiPAZ), Traslational Research Network of Pediatric Infectious Diseases (RITIP), and CIBERINFEC, Madrid, Spain.
  • Moreno E; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Blázquez-Gamero D; Pediatric Infectious Diseases Unit. Hospital Universitario 12 de Octubre. Universidad Complutense, Instituto de Investigación Hospital 12 de Octubre (imas12), Traslational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.
  • Vizcarra P; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Rodríguez M; Department of Microbiology, Facultad de Medicina, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
  • Jenkins R; Reactomix S.L., Granada 18003, Spain.
  • Sánchez-Conde M; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Ron R; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Norman F; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Moreno S; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain.
  • Ferrer M; Institute of Catalysis, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
  • Serrano-Villar S; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá and CIBERINFEC, Madrid, Spain. Electronic address: sergio.serrano@salud.madrid.org.
J Infect ; 85(1): 86-89, 2022 07.
Article em En | MEDLINE | ID: mdl-35490737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article